SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001626199-23-000062
Filing Date
2023-04-27
Accepted
2023-04-27 16:05:36
Documents
6
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14aproxy_2022.htm DEF 14A 637360
2 alpineislogolga09.jpg GRAPHIC 19148
3 compactuallypaidvscomptsr.jpg GRAPHIC 293665
4 compactuallypaidvsnl.jpg GRAPHIC 288789
5 proxycard_pagex1.jpg GRAPHIC 467592
6 proxycard_pagex2.jpg GRAPHIC 207111
  Complete submission text file 0001626199-23-000062.txt   2395572
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37449 | Film No.: 23856776
SIC: 2834 Pharmaceutical Preparations